Gwendolyn Binder-Scholl

(Dr. Gwendolyn Binder-Scholl Ph.D.)

Currently holds a position at Cabaletta Bio Inc

Positions

Position Company Period
Executive Vice President, Science & Technology Cabaletta Bio Inc Feb. 1, 2019 -
Chief Technology Officer Adaptimmune Therapeutics PLC Feb. 9, 2016 - Jan. 31, 2019
Executive Vice President - Adaptimmune LLC Adaptimmune Therapeutics PLC Jan. 1, 2012 - Feb. 9, 2016
Gwendolyn Binder-Scholl's trades of Cabaletta Bio Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-01-19 2024-01-19 PS Planned sale
700 -3.4%
20.33
USD 14,229
700 -3.4% 20.33 USD 14,229
2024-01-19 2024-01-19 PS Planned sale
10,300 -33.2%
19.54
USD 201,211
10,300 -33.2% 19.54 USD 201,211
2023-12-19 2023-12-19 PS Planned sale
3,132 -13.5%
22.22
USD 69,593
3,132 -13.5% 22.22 USD 69,593
2023-12-19 2023-12-19 PS Planned sale
7,868 -25.4%
21.76
USD 171,196
7,868 -25.4% 21.76 USD 171,196
2023-11-21 2023-11-20 PS Planned sale
7,458 -27.2%
18.02
USD 134,405
7,458 -27.2% 18.02 USD 134,405
2023-11-21 2023-11-20 PS Planned sale
3,542 -11.4%
17.39
USD 61,608
3,542 -11.4% 17.39 USD 61,608
2023-10-19 2023-10-19 PS Planned sale
408 -2.0%
14.28
USD 5,825
408 -2.0% 14.28 USD 5,825
2023-10-19 2023-10-19 PS Planned sale
10,592 -34.2%
13.32
USD 141,096
10,592 -34.2% 13.32 USD 141,096
2023-09-20 2023-09-19 PS Planned sale
700 -3.4%
18.50
USD 12,950
700 -3.4% 18.50 USD 12,950
2023-09-20 2023-09-19 PS Planned sale
10,300 -33.2%
17.50
USD 180,270
10,300 -33.2% 17.50 USD 180,270
2023-08-22 2023-08-21 PS Planned sale
300 -1.5%
13.82
USD 4,147
300 -1.5% 13.82 USD 4,147
2023-08-22 2023-08-21 PS Planned sale
10,700 -34.5%
13.41
USD 143,436
10,700 -34.5% 13.41 USD 143,436
2023-07-19 2023-07-19 PS Planned sale
2,815 -12.3%
14.26
USD 40,143
2,815 -12.3% 14.26 USD 40,143
2023-07-19 2023-07-19 PS Planned sale
8,185 -26.4%
13.67
USD 111,879
8,185 -26.4% 13.67 USD 111,879
2023-06-21 2023-06-20 PS Planned sale
11,000 -35.5%
12.99
USD 142,925
11,000 -35.5% 12.99 USD 142,925
2023-05-19 2023-05-19 PS Planned sale
22,000 -52.4%
11.81
USD 259,833
22,000 -52.4% 11.81 USD 259,833
2022-10-18 2022-10-18 B Purchase
20,000 +inf%
0.99
USD 19,894
20,000 +inf% 0.99 USD 19,894
// ... existing code ... // ... rest of the file ...